TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,705,990 | -92.6% | 69,760 | -90.9% | 0.18% | -93.5% |
| Q1 2021 | $36,756,790 | -18.2% | 762,589 | -11.7% | 2.76% | -47.6% |
| Q4 2020 | $44,937,529 | +64.1% | 863,851 | -15.6% | 5.27% | -13.4% |
| Q3 2020 | $27,384,311 | -43.8% | 1,023,330 | -59.1% | 6.08% | -8.9% |
| Q2 2020 | $48,724,779 | +101.2% | 2,501,272 | +1.6% | 6.68% | +11.0% |
| Q1 2020 | $24,217,588 | +166.8% | 2,461,137 | +200.9% | 6.02% | +275.5% |
| Q4 2019 | $9,077,835 | +109.0% | 817,823 | +5.7% | 1.60% | +19.0% |
| Q3 2019 | $4,343,208 | -43.2% | 773,501 | -12.5% | 1.35% | -37.1% |
| Q2 2019 | $7,642,284 | +27.0% | 883,501 | +18.0% | 2.14% | +21.9% |
| Q1 2019 | $6,018,696 | +2158.4% | 748,594 | +1051.7% | 1.76% | +1119.4% |
| Q4 2018 | $266,500 | -26.8% | 65,000 | 0.0% | 0.14% | -10.0% |
| Q3 2018 | $364,000 | -65.4% | 65,000 | -18.8% | 0.16% | -66.7% |
| Q2 2018 | $1,052,000 | -50.6% | 80,000 | -46.7% | 0.48% | -51.4% |
| Q1 2018 | $2,130,000 | – | 150,000 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |